BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bilynsky C, Millot N, Papa A. Radiation nanosensitizers in cancer therapy—From preclinical discoveries to the outcomes of early clinical trials. Bioengineering & Transla Med 2022;7. [DOI: 10.1002/btm2.10256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos AC, Yuan Z, Zhou Y. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Front Pharmacol 2022;13:908713. [PMID: 35721107 DOI: 10.3389/fphar.2022.908713] [Reference Citation Analysis]
2 Han O, Bromma K, Palmerley N, Bido AT, Monica M, Alhussan A, Howard PL, Brolo AG, Beckham W, Alexander AS, Chithrani DB. Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin. Pharmaceutics 2022;14:233. [DOI: 10.3390/pharmaceutics14020233] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]